Exercise may boost metabolism in aggressive breast cancer patients
NCT ID NCT07484776
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how well the body of women with early triple-negative breast cancer can switch between burning fat and sugar for energy—a trait called metabolic flexibility. Researchers will test if different types of exercise (moderate cardio, high-intensity cardio, or strength training) can improve this flexibility, muscle strength, body composition, and quality of life. Forty women will be tracked from diagnosis through treatment and a 12-week exercise program.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- exercise training (cardiovascular at FATmax, cardiovascular at MAP, or resistance training)
- What this could lead to
- If successful, this could show that specific exercise programs improve metabolic flexibility, strength, and quality of life for TNBC patients.
- What could go wrong
- This is a small, early-phase study with only 40 participants. Results may not apply to all patients, and exercise benefits may be modest or not sustained.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER (TNBC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universidad Europea de Madrid, Villaviciosa de Odón
Madrid, Madrid, 28670, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Can a Custom-Made vaccine outsmart Triple-Negative breast cancer?
- Can a drug combo outsmart a tough breast cancer subtype?
- Can a new drug combo outsmart triple-negative breast cancer?
- Can your own immune cells fight advanced cancer?
- Can a biomarker spare breast cancer patients from harsh chemo?